Stillcanna signs Supply Agreement LOI with Leading European Pharma and Wellness Group Brains Bioceutical Corp.
Posted On June 15, 2020
- Company to supply specific CBD products to European Operations
- is pleased to announce that it has signed a supply agreement with Brains Bioceutical Corp (” Brains” ) to supply bulk CBD for processing to their European operations.
- Brains is a global leader of plant-based cannabidiol (CBD) as an Active Pharmaceutical Ingredient (API) for both Pharmaceutical and Nutraceutical use.
- brainsbio.com is a leader in GMP-certified production of naturally-sourced CBD active pharmaceutical ingredients (API) for the Pharmaceutical and Nutraceutical industries.
- Regarding Forward Looking Statements: This release includes certain statements and information that constitute forward-looking information within the meaning of applicable Canadian securities laws .
Read full article: finance.yahoo.com